Clinical trials
Recruiting Adenocarcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 14 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 4 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 4 |
| AstraZeneca | 2 |
| Fox Chase Cancer Center | 2 |
| University of Chicago | 2 |
| Acerand Therapeutics (Hong Kong) Limited | 1 |
| AdventHealth | 1 |
| BigHat Biosciences, Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| Canadian Cancer Trials Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 43 |
| Prostatic Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Pancreatic Neoplasms | 6 |
| Carcinoma | 5 |
| Neoplasms | 5 |
| Carcinoma, Squamous Cell | 4 |
| Esophageal Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Rectal Neoplasms | 4 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.